Original Research

Clobetasol Propionate Spray 0.05% for the Treatment of Moderate to Severe Plaque Psoriasis

Clobetasol propionate is a super-high potent class 1 topical corticosteroid available in several formulations, including a spray formulation that is approved for use up to 4 weeks in patients aged 18 years and older with moderate to severe plaque psoriasis. The efficacy and safety of clobetasol propionate spray 0.05% has been extensively evaluated in clinical trials in more than 2200 patients with moderate to severe plaque psoriasis. This article reviews the efficacy, safety, and tolerability of clobetasol propionate spray 0.05%. Clobetasol propionate spray 0.05% is a topical product with a documented efficacy and safety profile with good acceptability in patients with moderate to severe plaque psoriasis.


 

Recommended Reading

Infliximab Switch Clears Psoriasis in Etanercept Nonresponders
MDedge Dermatology
Evidence Builds for Switching Biologics After Psoriasis Treatment Failure
MDedge Dermatology
The Whys and How of Stopping Biologics
MDedge Dermatology
For Etanercept Nonresponders, Switch or Escalate?
MDedge Dermatology
Blog: Top 10 Stories of 2011
MDedge Dermatology
Preterm Delivery a Risk in Systemic Sclerosis
MDedge Dermatology
Ondansetron Quells Methotrexate-Induced Nausea
MDedge Dermatology
Malignancy Rates Remain Stable in Ustekinumab-Treated Patients
MDedge Dermatology
Earlier Is Better in Psoriasis Treatment
MDedge Dermatology
Laser and Light Devices for Psoriasis, Part 1: Excimer Laser and Phototherapy
MDedge Dermatology